Newtype Industries, a defense AI company, announced on July 29 that it held discussions with the Army CBR (Chemical, Biological, and Radiological) School regarding cooperative measures in the CBR field.


Photo by Newtype Industries

Photo by Newtype Industries

View original image

The two organizations exchanged views on collaborative directions on the 24th, following the signing of a memorandum of understanding (MOU) on May 11. This cooperation also ties into the government’s ongoing defense industry innovation policies. In February, the Ministry of SMEs and Startups and the Defense Acquisition Program Administration announced a support plan to foster innovative defense companies and connect startup-developed products to military demonstration programs.


Newtype Industries is currently developing a 'CBR AI Advisor' to assist commanders' decision-making in CBR situations. The goal is to enhance response capabilities to CBR warfare by enabling AI to integrate contamination data and unit status in real time, and propose optimal response strategies during CBR contamination events.


Jungwon Cho, CEO of Newtype Industries, stated, "This is a meaningful opportunity to extend technologies that secure victory on the battlefield into the CBR domain," adding, "We will strive to advance AI technologies supporting commanders' decision-making in CBR scenarios through Newtype's AI capabilities."



Meanwhile, although only in its first year since establishment, Newtype Industries is already working on technology validation in overseas defense fields. The company is preparing for system integration tests with a next-generation command and control system in cooperation with a unit of the U.S. Army, and is also conducting experimental battle tests with the Ukrainian ground forces. Discussions with Ukraine’s Ministry of Defense regarding the scale and method of adoption are ongoing.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing